The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Equip EHV 1,4 Suspension for injection

Zoetis Belgium S.A.VPA10387/028/001

Main Information

Trade NameEquip EHV 1,4 Suspension for injection
Active SubstancesEquine herpes virus 4, strain 405/76 inactivated
Equine herpes virus 1, strain 438/77 inactivated
Dosage FormSuspension for injection
Licence HolderZoetis Belgium S.A.
License Holder Address2nd Floor, Building 10
Cherrywood Business Park, Loughlinstown
Co Dublin
Licence NumberVPA10387/028/001

Group Information

ATC CodeQI05AA05 equine rhinopneumonitis virus
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued26/09/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back